LASR Stock: Defense Backlog vs. Margin Risk in 2026 Outlook

Aerospace & defense revenue rose 60% YoY to $175M in 2025 and nLIGHT reports a funded backlog of ~$162M as of Dec. 31, 2025, supporting management's target for double-digit A&D growth in 2026; Q1 2026 revenue guidance is $70–$76M (Zacks consensus $70.6M, ~36.6% YoY). The company expects a deliberate ~$25–$30M 2026 revenue headwind from exiting cutting & welding, product gross margin stepped down to 37.3% in Q4 2025, and management guides Q1 consolidated gross margin to the mid‑to‑high‑20s% with positive adjusted EBITDA, making quarter-to-quarter results sensitive to milestone timing, mix and factory utilization. Shares are up 66.5% YTD but valuation appears stretched (forward P/S 12.29 vs sector 5.67) and Zacks assigns a #4 (Sell), leaving a mixed risk/reward profile.

Analysis

nLIGHT’s pivot toward defense increases revenue quality but also concentrates operational risk in milestone-driven programs; the payout profile shifts from steady industrial sales to lumpy, testing-dependent deliveries. That creates a two-stage margin path: an initial hit from de-emphasized industrial lines (fixed-costs stranded, lower utilization) followed by a potential step-up if defense production ramps and fixed-costs are absorbed — the timing of that crossover is the dominant earnings risk for the next 6–18 months.

The industrial exit is a net positive for competing industrial OEMs and component suppliers who can pick up displaced demand with minimal incremental R&D; expect incremental order flow for fiber-laser incumbents and optics houses to show up within 1–2 quarters and to compress mid-term pricing power for any supplier that lacks defense-qualified product lines. Conversely, nLIGHT’s reliance on prime contractors and test cycles increases exposure to single-program event risk: a multi-quarter testing delay at one prime can wipe out what looks like a multi-year revenue target on paper.

Key catalysts to watch are sequential factory utilization, defense-funded award cadence, and development-revenue conversion rates — each will drive binary moves in reported margins and cash flow. Tail risks include prolonged test failures or funding delays at prime customers and a sharper-than-expected softening in microfabrication demand; both would materially widen downside over a 3–9 month horizon despite the longer-term strategic rationale.

Key Decisions for Investors

• Pair trade (3–9 month): Long IPGP, Short LASR (equal notional). Rationale: capture industrial share pickup and more stable revenue profile at IPGP vs milestone concentration at LASR. Target asymmetric return: +25–35% on the pair if LASR misses utilization/milestone cadence; risk approx -15–20% if LASR re-rates on smooth defense execution.
• Volatility hedge (0–6 month): Buy LASR 3–6 month puts sized to 25–50% of equity exposure and finance by selling 1–2 month covered calls on existing LASR holdings. Rationale: protects against near-term milestone slip while retaining upside from a successful production ramp. Breakeven: protection kicks in on a >15% downside move; capped upside from sold calls limits cost.
• Event-driven long (6–18 month): Go long LITE (or optical-component peers) on a 6–12 month view, hedge with 9–12 month OTM puts. Rationale: these names should capture displaced industrial dollars and benefit if defense OEMs broaden supplier base. Target return 30–50% with downside protection to limit drawdown to ~25%.
• Trigger-based long LASR (conditional, 3–12 month): Add LASR only after two consecutive quarters of higher factory utilization and improving product gross margins reported by management. Risk/reward: asymmetric — ~2x upside if utilization sustains and backlog converts; downside 35–45% if milestones slip before scale benefits materialize.